This higher dose can be administered as a single 100mg injection in the morning or split into two 50mg doses taken 12 hours apart (morning and afternoon)
These include mild soreness, redness, or a warm sensation at the injection site, brief lightheadedness or flushing shortly after administration, and occasional mild nausea in the first few sessions as the body adjusts to the lipotropic compounds
AOD-9604 FDA Approval History At a glance FDA approval status / Never approved for any indication in the United States NDA filing history / No New Drug Application has ever been submitted to FDA Chemical identity / Synthetic peptide corresponding to amino acids 176-191 of human growth hormone, with a tyrosine residue added at the C-terminus Developer / Metabolic Pharmaceuticals Ltd (Melbourne, Australia), now defunct Clinical trial outcome / Phase IIb trial (2007) failed to meet primary efficacy endpoint for obesity FDA compounding status / Placed on Category 2 list
A: There's no strong human evidence that it directly "burns fat" through thermogenesis or lipolysis pathways, the way true fat-loss drugs aim to do
Be sure to ask about specifics of the laser or light system that will be utilized for your treatment
